Mehul Desai M.D. is a medical officer in the Division of Rare Diseases and Medical Genetics (DRDMG), Office of New Drugs (OND), Center for Drug Evaluation Research (CDER), with the US Food and Drug Administration (FDA). Dr. Desai has clinical development experience in both the pharmaceutical industry as well as FDA. Dr. Desai received his M.D. degree from Boston University School of Medicine. He completed a residency in Internal Medicine in Rochester, New York and a fellowship in Clinical Pharmacology at Georgetown/Indiana University.